Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hemobiotech Inc (HMBT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Hemobiotech Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1301348.
Total stock buying since 2005: $21,684.
Total stock sales since 2005: $1,170,000.
Total stock option exercises since 2005: $130,333.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 0 | $0 | 651,668 | $130,333 |
| 2007 | 0 | $0 | 1,000,000 | $1,170,000 | 0 | $0 |
| 2006 | 10,000 | $18,684 | 0 | $0 | 0 | $0 |
| 2005 | 2,000 | $3,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-10 | 0 | $0 | 0 | $0 | 651,668 | $130,333 |
| 2007-03 | 0 | $0 | 1,000,000 | $1,170,000 | 0 | $0 |
| 2006-03 | 5,000 | $8,934 | 0 | $0 | 0 | $0 |
| 2006-02 | 5,000 | $9,750 | 0 | $0 | 0 | $0 |
| 2005-11 | 2,000 | $3,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-10-30 | Bollon Arthur (Chief Executive Officer) | Option Ex | 651,668 | .20 | 130,333 |
| 2007-03-14 | Nino Ghassan | Sale | 1,000,000 | 1.17 | 1,170,000 |
| 2006-03-20 | Baron Robert (Director) | Buy | 3,150 | 1.75 | 5,512 |
| 2006-03-17 | Baron Robert (Director) | Buy | 1,850 | 1.85 | 3,422 |
| 2006-02-23 | Baron Robert (Director) | Buy | 5,000 | 1.95 | 9,750 |
| 2005-11-21 | Rosenblum Mark J (Chief Financial Officer) | Buy | 2,000 | 1.50 | 3,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of HMBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hemobiotech Inc (symbol HMBT, CIK number 1301348) see the Securities and Exchange Commission (SEC) website.